Openbank reaches milestone with over 100k customers in Mexico

Héctor Grisi Chief Executive Officer Santander Group
Héctor Grisi Chief Executive Officer - Santander Group
0Comments

Openbank, the digital banking arm of Grupo Santander, has reported reaching 110,000 customers in Mexico within four months of its launch. This growth signifies a strong demand among Mexicans for digital financial services that are accessible and secure. Since its February debut, Openbank has attracted over EUR 60 million in customer deposits, highlighting user trust in the bank’s offerings.

Matías Núñez Castro, CEO of Openbank Mexico, highlighted the range of digital products available: “Openbank provides a complete range of fully digital products, from the Open Light and Open+ Debit Accounts with a fixed annual return of 10%, to the Open Credit Card, which offers 3% cashback and enables users to finance online purchases over three months interest free.” He also emphasized enhancements in security with new protections for online credit card purchases.

The bank has introduced features such as an intelligent assistant and a customer service chatbot to improve customer interaction. Looking ahead, Openbank plans to expand its product offerings by introducing insurance and personal loans to further develop its digital services in Mexico.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.